Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4

Immunology

Volumn 111, Issue 2, 2004, Pages 212-222

  Darlow, John M ^a   Farrell, Alex M ^a   Stott, David I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CASE REPORT; GENE FUNCTION; GENE SEQUENCE; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; HYPERIMMUNOGLOBULINEMIA M; IMMUNOPATHOLOGY; MALE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC HYPERMUTATION;

ADULT; APOPTOSIS; B-LYMPHOCYTES; BASE SEQUENCE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSCRIPTION, GENETIC;

EID: 0842265543     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0019-2805.2003.01790.x     Document Type: Article

References (35)

1. Spickett GP, Farrant J, North ME, Zhang JG, Morgan L, Webster AD. Common variable immunodeficiency: how many diseases? Immunol Today 1997; 18:325-8.
2. WHO Scientific Group. Primary immunodeficiency diseases. Report of a WHO Scientific Group. Clin Exp Immunol 1997; 109(Suppl. 1):1-28.
3. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190-7.
4. Webster ADB. Common variable immunodeficiency. Immunol Allergy Clin N Am 2001; 21:1-22.
5. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency, clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48.
6. Gulino AV, Notarangelo LD Hyper IgM syndromes. Curr Opin Rheumatol 2003; 15:422-9.
7. Allen RC, Armitage RJ, Conley ME et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259:990-3.
8. Aruffo A, Farrington M, Hollenbaugh D et al. The CD40 ligand, gp39, is detective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72:291-300.
9. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint BGCD. 40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993; 361:541-3.
10. Fuleihan R, Ramesh N, Loh R et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1993; 90:2170-3.
11. Korthauer U, Graf D, Mages HW et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361:539-41.
12. Ramesh N, Fuleihan R, Ramesh V et al. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int Immunol 1993; 5:769-73.
13. Mayer L, Kwan SP, Thompson C, Ko HS, Chiorazzi N, Waldmann T, Rosen F. Evidence for a defect in 'switch' T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med 1986; 314:409-13.
14. Revy P, Muto T, Levy Y et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 2000; 102:565-75.
15. Ferrari S, Giliani S, Insalaco A et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 2001; 98:12614-9.
16. Kutukculer N, Moratto D, Aydinok Y, Lougaris V, Aksoylar S, Plebani A, Genel F, Notarangelo LD. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr 2003; 142:194-6.
17. Imai K, Slupphaug G, Lee W-I et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class switch recombination. Nat Immunol 2003; 4:1023-8.
18. Zonana J, Elder ME, Schneider LC et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000; 67:1555-62.
19. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001; 2:223-8.
20. Döffinger R, Smahi A, Bessia C et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001; 27:277-85.
21. Orange JS, Brodeur SR, Jain A et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 2002; 109:1501-9.
22. Imai K, Catalan N, Plebani A et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 2003; 112:136-42.
23. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102:553-63.
24. Weller S, Faili A, Garcia C et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA 2001; 98:1166-70.
25. Levy Y, Gupta N, Le Deist F, Garcia C, Fischer A, Weill JC, Reynaud CA. Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. Proc Natl Acad Sci USA 1998; 95:13135-40.
26. Bonhomme D, Hammarstrom L, Webster D et al. Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 2000; 165: 4725-30.
27. Shimadzu M, Nunoi H, Terasaki H, Ninomiya R, Iwata M, Kanegasaka S, Matsuda I. Structural organization of the gene for CD40 ligand, molecular analysis for diagnosis of X-linked hyper-IgM syndrome. Biochim Biophys Acta 1995; 1260:67-72.
28. Lin Q, Rohrer J, Allen RC et al. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest 1996; 97:196-201.
29. Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998; 92:2421-34.
30. Pattanapanyasat K, Thepthai C, Lamchiagdhase P et al. Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry 2000; 42:11-7.
31. Klonowski KD, Monestier M. Ig. heavy-chain gene revision: leaping towards autoimmunity. Trends Immunol 2001; 22:400-5.
32. Kouskoff V, Nemazee D. Role of receptor editing and revision in shaping the B and T lymphocyte repertoire. Life Sci 2001; 69: 1105-13.
33. H gene replacement to the primary B cell repertoire. Immunity 2003; 19:21-31.
34. Rosner K, Winter DB, Tarone RE, Skovgaard GL, Bohr VA, Gearhart PJ. Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes. Immunology 2001; 103:179-87.
35. Schroeder HW, Jr, Zhang L, Philips JB, III. Slow, programmed maturation of the immunoglobulin HCDR3 repertoire during the third trimester of fetal life. Blood 2001; 98:2745-51.